DXS International Plc (AQSE: DXSP): Notice Of AGM
DXS INTERNATIONAL PLC (AQSE: DXSP)
Notice of AGM
DXS International plc ( AQSE: DXSP ), the UK healthcare technology provider, announces that it has published its Notice of its Annual General Meeting (“AGM”) which will be held at DXS offices at Elm House, Tanshire Park, Shackleford Road. Elstead, Surrey GU8 6LB on 19th November 2026 at 11.30 a.m.
The Notice of AGM, together with the accounts, have been dispatched to all shareholders.
An electronic copy of the Notice of AGM is also available on the Company's website:
The Directors of DXS International plc accept responsibility for this announcement.
Contacts:
David Immelman, CEO
DXS International plc
Tel: 01252 719800
AQSE Corporate Broker and Corporate Advisor
Hybridan LLP
Claire Louise Noyce
Tel: 020 3764 2341
Notes to Editors
About DXS:
DXS International presents up to date treatment guidelines and recommendations, from Clinical Commissioning Groups and other trusted NHS sources, to doctors, nurses and pharmacists in their workflow and during the patient consultation. This effective clinical decision support ultimately translates to improved healthcare outcomes delivered more cost effectively and which should significantly contribute towards the NHS achieving its projected efficiency savings.
Attachment
-
AGM Notice 26 October 2026
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Comments
No comment